This site is intended for healthcare professionals only
LoginRegister
Cipla Announces Leadership Change, USD 100 Million Investment, Approves Inzpera MergerDoP orders NPPA to reassess price of Cipla's Advent, Synclar and Azee drugs
Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical NegligenceFortis trademark to be auctioned: HC order
Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017PM Modi inaugurates medical devices plant in Vapi
PM ModiPM Modi inaugurates Lyfius Pharma Penicillin-G Facility in AP
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealEli Lilly Kisunla bags marketing authorization in Great Britain to treat mild cognitive impairment,...
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca Gets CDSCO Panels Nod to study anticancer drug AZD0901
Lupin rolls out constipation drug Prucalopride in US after USFDA nod18 formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and BiosimilarsSun Pharma Winlevi cream 1% reduces Sebum levels, suitable for combination with other commonly used...
Pharma Companies Told to Cut Prices of 17 Duty Exempt Cancer DrugsReduce price of 3 anti-cancer drugs: Govt asks manufacturers
Granules India packaging facility in US successfully completes USFDA inspectionSai Life Sciences receives EIRs from USFDA for India RnD, Manufacturing facilities
Paracetamol49 drugs samples including PAN 40, Calvam 625, Zerodol-SP Tablet fail to meet CDSCO quality test
Maharashtra Govt Seeks Rs 26.5 Crore for Track-and-Trace SystemCDSCO declares 4 formulations as spurious including PAN D, SHELCAL 500
X